ArticleJournal of hematology & oncology2021

Correction to: HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8+ T and NK cells: a novel therapeutic tumour vaccine.

Zhaojin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.